Trials / Enrolling By Invitation
Enrolling By InvitationNCT05752032
A Long Term Follow-up Study of Subjects Who Received ICM-203 or Matching Placebo
- Status
- Enrolling By Invitation
- Phase
- —
- Study type
- Observational
- Enrollment
- 16 (estimated)
- Sponsor
- ICM Co. Ltd. · Industry
- Sex
- All
- Age
- 50 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
This is an observational study of the long term safety and efficacy of ICM-203.
Detailed description
Subjects who have received ICM-203 or matching placebo from ICM-203 clinical studies will be enrolled. Subjects will be contacted annually to collect safety and efficacy outcomes until 5 years after the last dose of ICM-203 or placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | ICM-203 | Long term follow-up |
| DRUG | Placebo | Long term follow-up |
Timeline
- Start date
- 2023-03-16
- Primary completion
- 2028-12-01
- Completion
- 2028-12-01
- First posted
- 2023-03-02
- Last updated
- 2026-03-27
Locations
2 sites across 1 country: Australia
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05752032. Inclusion in this directory is not an endorsement.